Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01436032 · ClinicalTrials.gov registry record · Phase 3
Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery
A Phase 3 study, sponsored by Alkermes.
- Terminated
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
NCT01436032 is a Phase 3 study that was terminated before completion, run by Alkermes. The registered enrollment target is 50 participants.
The verdict
NCT01436032, a Phase 3 study, was terminated before completion, sponsored by Alkermes.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the analgesic efficacy and safety of N1539 in subjects undergoing abdominal laparoscopic surgery.
Interventions
- DRUG Placebo
- DRUG Ketorolac Tromethamine
- DRUG N1539
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01436032
The ClinicalTrials.gov registry entry for NCT01436032 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alkermes, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01436032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01436032 about?
NCT01436032 is a clinical study titled "Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery". The purpose of this study is to determine the analgesic efficacy and safety of N1539 in subjects undergoing abdominal laparoscopic surgery.
What is the current status of trial NCT01436032?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2011-10. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01436032?
The interventions under investigation include: Placebo (DRUG), Ketorolac Tromethamine (DRUG), N1539 (DRUG).
Who is sponsoring clinical trial NCT01436032?
This trial is sponsored by Alkermes, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.